首页 > 市场调查报告书 > 製药

生物製剂

市场调查报告书

商品编码

2008082

重组人白蛋白市场：依原料、应用、最终使用者及地区划分

rHu Albumin Market, By Source, By Application, By End User, By Geography

出版日期: 2026年03月16日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2026年重组人白蛋白市场规模估计为876亿美元，预计2033年将达2778亿美元。预计2026年至2033年，其复合年增长率将达13.6%。

分析范围		分析详情
基准年	2025	市场规模（2026 年）	876亿美元
效能数据	2020-2024	预测期	2026-2033
预测期（2026-2033 年）复合年增长率	13.60%	预计金额（2033 年）	2778亿美元

生物製药是指利用生物技术，以生物来源的原料为原料生产的药物。这些药物通常以组织培养方法生产，利用干细胞、哺乳动物细胞和其他类似材料。

组织培养方法依赖细胞培养基。这些培养基含有许多必需成分，包括碳水化合物、胺基酸、维生素、矿物质和pH缓衝系统，这些成分对于维持健康的细胞培养以及提供重组治疗分子和生物製药生产所需的营养素至关重要。

重组人体血清蛋白是细胞培养中的重要成分。重组人体血清蛋白（rHu）广泛应用于细胞培养基和干细胞治疗。它主要作为细胞培养基的营养补充剂和稳定剂。此外，它在干细胞治疗的冷冻保存过程中也扮演着重要角色。

市场动态

市场参与企业正着力于多种策略，包括分销协议，预计这些策略将在预测期内推动市场成长。 2021年4月，以科学为主导的生物技术公司Albumedix宣布，已与知名试剂供应商FUJIFILM胶片和光纯药株式会社达成分销协议，其产品将在日本和中国（包括香港）销售。

研究机构和学术机构正集中精力进行重组人白蛋白（rHu白蛋白）相关的研发活动，预计将推动全球rHu白蛋白市场在预测期内的成长。例如，2019年6月，位于长春的中国领先研究型大学附属吉林大学第一医院启动了一项I期、单中心、随机、双盲、安慰剂对照、单剂量递增试验，旨在评估重组人体血清蛋白注射液在接受腹水治疗的健康志愿者中的安全性、耐受性、药代动力学和免疫抗原性。

预计该地区重组人白蛋白（rHu白蛋白）研发活动的增加将推动全球rHu白蛋白市场的成长。例如，根据clinicaltrials.gov网站上发表的一项研究，北京一家以研发为导向的高科技公司Protgen Ltd于2021年4月8日启动了一项试验。本试验采用单中心、随机、双盲、剂量递增、安慰剂对照设计，旨在评估健康受试者单次注射重组人血清白蛋白的安全性、耐受性、药物动力学和有效性。该试验预计于2022年12月31日完成。

本报告的主要特点

本报告对全球重组人白蛋白市场进行了详细分析，包括市场规模和预测期（2026-2033 年）的复合年增长率，以 2025 年为基准年。
此外，它还确定了每个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
此外，它还提供了有关市场驱动因素和限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
本文根据以下参数，介绍了全球 rHu 白蛋白市场主要企业的概况：公司概况、产品系列、主要亮点、财务表现和策略。
本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、产品线更新、市场扩张和行销策略做出明智的决策。
《全球重组人白蛋白市场》报告面向该行业的各种相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过分析全球重组人白蛋白市场中使用的各种策略矩阵来促进决策。

北美洲
我们
加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 俄罗斯
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
中东
- GCC
- 以色列
- 其他中东国家
非洲
- 南非
- 中非
- 北非

第八章竞争情势

公司简介
- Merck KGaA
- HiMedia Laboratories Pvt. Ltd.
- Albumin Bioscience
- Albumedix
- ScienCell Research Laboratories, Inc.
- InVitria
- Lazuline Biotech Private Limited
- Lee Biosolutions, Inc.
- Abcam Plc
- Shandong Kingtone Biotechnology Co.,Ltd.

第九章

分析方法
关于 Coherent Market Insights
联络地址

简介目录

Product Code: CMI5040

rHu Albumin Market is estimated to be valued at USD 87.6 Bn in 2026 and is expected to reach USD 277.8 Bn by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 87.6 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	13.60%	2033 Value Projection:	USD 277.8 Bn

A biopharmaceutical is a medicinal product that is derived from biological sources such as animals, humans, and microorganisms using biotechnology. They are manufactured using stem cells, mammalian cells, etc., through tissue culture methods.

Tissue culture methods rely on cell culture medium, which contains a number of essential components such as carbohydrates, amino acids, vitamins, minerals, and a pH buffer system that keep the cell culture healthy and supply nutrition for the production of therapeutic recombinant molecules or biopharmaceuticals.

One such component of cell culture is recombinant human albumin. Recombinant human albumin (rHu) has applications in cell culture media and stem cell therapy. It is particularly a nutrient supplement and stabilizer in the cell culture medium. Moreover, it plays a role in cryopreservation for stem cell therapies.

Market Dynamics

Market players are focusing on various strategies such as distribution agreements which is expected to drive market growth over the forecast period. In April 2021, Albumedix, a science-driven, biotechnology Company, announced that they had entered into a distribution agreement with established and well recognized reagent supplier Fujifilm Wako Pure Chemical Corporation in Japan and China including Hong Kong.

Research and/or academic institutes are focused on research and development activities related to rHu albumin, which is expected to drive growth of the global rHu albumin market over the forecast period. For instance, in June 2019, The First Hospital of Jilin University, a leading national research university located in Changchun, China, initiated a phase I, single-center, randomized, double-blind, placebo-controlled single dose escalation study to evaluate the safety, tolerability, pharmacokinetics, and immunogenicity of recombinant human albumin injection in healthy volunteers for treatment of ascites.

Increasing research and development activities of rHu albumin in the region is expected to drive growth of the global rHu albumin market. For instance, according to a study published in clinicaltrials.gov, a trial, which started on April 8, 2021, is being conducted by Protgen Ltd, a research and development-oriented high-tech enterprise, based in Beijing, China. The trial is aimed at adopting a single-center, randomized, double-blind, dose-escalation, placebo-controlled design to evaluate the safety, tolerability, pharmacokinetics, and efficacy of a single administration of recombinant human serum albumin in healthy subjects. The study is estimated to be completed by December 31, 2022.

Key features of the study

This report provides an in-depth analysis of the global rHu albumin market , provides market size (USD Bn), and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global rHu albumin market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Merck KGaA, HiMedia Laboratories Pvt. Ltd., Albumin Bioscience, Albumedix, ScienCell Research Laboratories, Inc., InVitria, Lazuline Biotech Private Limited, Lee Biosolutions, Inc., Abcam Plc, and Shandong Kingtone Biotechnology Co.,Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The Global rHu Albumin Market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global rHu albumin market

Market Segmentation

By Source
- Oryza sativa
- Pichia pastoris
- Others
By Application
- Cell Culture Media
- Nutrient and stabilizer
- Medium Supplement
- Stem Cell Therapy
- Drug Formulations
- Cryopreservation
- Others
By End User
- Pharmaceutical and Biotechnological Industry
- Research Institutes
By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Merck KGaA
- HiMedia Laboratories Pvt. Ltd.
- Albumin Bioscience
- Albumedix
- ScienCell Research Laboratories, Inc.
- InVitria
- Lazuline Biotech Private Limited
- Lee Biosolutions, Inc.
- Abcam Plc
- Shandong Kingtone Biotechnology Co.,Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Source
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Porter's Analysis
Industry Trends
Key Highlights
Epidemiology
Reimbursement Scenario
Regulatory Scenario
Product Launch and Approvals
Acquisition and Collaboration Scenario

4. Global rHu Albumin Market, By Source, 2026-2033 (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Oryza Sativa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Pichia pastoris
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global rHu Albumin Market, By Application, 2026-2033 (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Cell Culture Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  - Nutrient and stabilizer
  - Medium Supplement
Stem Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Drug Formulations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cryopreservation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global rHu Albumin Market, By End User, 2026-2033 (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Pharmaceutical & Biotechnology Industry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global rHu Albumin Market, By Region, 2026-2033 (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
- Regional Trends
North America
- Market Size and Forecast, By Source, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application, 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
U.S.
Canada
Latin America
- Market Size and Forecast, By Source, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application, 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Source, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application, 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Source, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application, 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Source, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application, 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Source, 2021-2033 (USD Bn)
- Market Size and Forecast, By Application, 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country/Region, 2021-2033 (USD Bn)
  - South Africa
  - Central Africa
  - North Africa

8. Competitive Landscape

Company Profiles
- Merck KGaA
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- HiMedia Laboratories Pvt. Ltd.
- Albumin Bioscience
- Albumedix
- ScienCell Research Laboratories, Inc.
- InVitria
- Lazuline Biotech Private Limited
- Lee Biosolutions, Inc.
- Abcam Plc
- Shandong Kingtone Biotechnology Co.,Ltd.

9. Section

Research Methodology
About us
Contact

02-2729-4219

+886-2-2729-4219

License/价格

重组人白蛋白市场：依原料、应用、最终使用者及地区划分

rHu Albumin Market, By Source, By Application, By End User, By Geography

市场动态